Current Neurovascular Research

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back Subscribe
Research Article

Effect of 3',4'-dihydroxy Flavonol Supplementation for One Week on Renal Functions and Lipid Peroxidation as Distant Organ Damage After Brain Ischemia-reperfusion in Rats

Author(s): Merve Gulen, Tugce Aladag, Gozde Acar, Abdulkerim Kasim Baltaci and Rasim Mogulkoc*

Volume 22, Issue 3, 2025

Published on: 21 October, 2025

Page: [237 - 244] Pages: 8

DOI: 10.2174/0115672026405662251007105724

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: The objective of this study was to investigate the effects of 3',4'- dihydroxyflavonol (DiOHF) on oxidative and antioxidant systems in kidney tissue and on renal function as distant organ damage following brain ischemia-reperfusion.

Methods: This study was conducted on 28 male Wistar-Albino rats, which were divided into four groups: Control, Sham, Ischemia-Reperfusion (I/R), and Ischemia-Reperfusion + DiOHF. Kidney tissue samples were collected to analyze malondialdehyde (MDA) and glutathione (GSH) levels. Additionally, concentrations of electrolytes (Ca, Cl, Na, K, and P), as well as urea, uric acid, creatinine, and urinary microprotein levels, were measured.

Results: Brain ischemia-reperfusion led to increased malondialdehyde (MDA) levels in both the kidney medulla and cortex, indicating oxidative stress in these distant organs, while glutathione (GSH) levels were suppressed. Additionally, ischemia-reperfusion caused elevations in blood and urine concentrations of urea, uric acid, creatinine, and urinary microproteins.

Discussion: This experimental model significantly elevated urea, uric acid, and creatinine levels, key indicators of kidney function, and similarly increased urinary microprotein loss. While our study demonstrates the detrimental effects of focal brain ischemia-reperfusion on kidney function as a distant organ, further research is needed to investigate its impact on other organs to gain a more comprehensive understanding of distant organ damage.

Conclusion: Results from this experimental model indicate that cerebral ischemia-reperfusion in rats suppresses the antioxidant system and increases oxidative stress in kidney tissue, leading to impaired renal function. However, a 1-week DiOHF treatment mitigated this damage by enhancing the antioxidant defense system.

Keywords: 3', 4'-dihydroxyflavonol, brain ischemia reperfusion, kidney injury, glutathione, malondialdehyde, elements.

[1]
Siwicka-Gieroba D, Robba C, Gołacki J, Badenes R, Dabrowski W. Cerebral oxygen delivery and consumption in brain-injured patients. J Pers Med 2022; 12(11): 1763.
[http://dx.doi.org/10.3390/jpm12111763] [PMID: 36573716]
[2]
Bozic M. Advances in understanding molecular mechanisms involved in chronic kidney injury and repair. IJMS 2024.
[3]
Akbas H, Ozden M, Kanko M, et al. Protective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injury. J Int Med Res 2005; 33(5): 528-36.
[http://dx.doi.org/10.1177/147323000503300508]
[4]
Dasdelen D, Solmaz M, Mogulkoc R, Baltaci AK, Erdogan E. Apoptosis of hippocampus and cerebellum induced with brain ischemia reperfusion prevented by 3′,4′-dihydroxyflavonol (DiOHF). Biotech Histochem 2024; 99(5): 225-37.
[http://dx.doi.org/10.1080/10520295.2024.2360496] [PMID: 38940209]
[5]
Durak VA, Sezer O, Armagan E, Çıkrıklar Hİ, Çelebi H. Analysis of fluid and electrolyte imbalances in patients diagnosed with acute cerebrovascular disease. UUFMJ 2022; 48(3): 307-13.
[6]
Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci 2007; 10(11): 1377-86.
[http://dx.doi.org/10.1038/nn2004] [PMID: 17965658]
[7]
Serna J, Bergwitz C. Importance of dietary phosphorus for bone metabolism and healthy aging. Nutrients 2020; 12(10): 3001.
[http://dx.doi.org/10.3390/nu12103001] [PMID: 33007883]
[8]
Lerink LJS, de Kok MJC, Mulvey JF, et al. Preclinical models versus clinical renal ischemia reperfusion injury: A systematic review based on metabolic signatures. Am J Transplant 2022; 22(2): 344-70.
[http://dx.doi.org/10.1111/ajt.16868] [PMID: 34657378]
[9]
Xu L, Li C, Wan T, et al. Targeting uric acid: A promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases. Cell Commun Signal 2025; 23(1): 4.
[http://dx.doi.org/10.1186/s12964-024-01965-4] [PMID: 39754256]
[10]
Duffy EE, Assad EG, Kalish BT, Greenberg ME. Small but mighty: The rise of microprotein biology in neuroscience. Front Mol Neurosci 17: 1386219.
[http://dx.doi.org/10.3389/fnmol.2024.1386219] [PMID: 38807924]
[11]
Miller B, Kim SJ, Kumagai H, Yen K, Cohen P. Mitochondria-derived peptides in aging and healthspan. J Clin Invest 2022; 132(9): 158449.
[http://dx.doi.org/10.1172/JCI158449] [PMID: 35499074]
[12]
Jiang W, Chen Z, Xu J, et al. Proteinuria is a risk factor for acute kidney injury after cardiac surgery in patients with stages 3–4 chronic kidney disease: A case control study. BMC Cardiovasc Disord 2023; 23(1): 77.
[http://dx.doi.org/10.1186/s12872-023-03102-4] [PMID: 36759765]
[13]
Dasdelen D, Solmaz M, Menevse E, Mogulkoc R, Baltaci AK, Erdogan E. Increased apoptosis, tumor necrosis factor-α, and DNA damage attenuated by 3′,4′-dihydroxyflavonol in rats with brain İschemia-reperfusion. Indian J Pharmacol 2021; 53(1): 39-49.
[http://dx.doi.org/10.4103/ijp.IJP_727_20] [PMID: 33975998]
[14]
Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86(1): 271-8.
[http://dx.doi.org/10.1016/0003-2697(78)90342-1] [PMID: 655387]
[15]
Kaur J, Kaur T, Sharma AK, et al. Fenofibrate attenuates ischemia reperfusion‐induced acute kidney injury and associated liver dysfunction in rats. Drug Dev Res 2021; 82(3): 412-21.
[http://dx.doi.org/10.1002/ddr.21764] [PMID: 33226649]
[16]
Hu Y, Nan Y, Lin H, et al. Celastrol ameliorates hypoxic-ischemic brain injury in neonatal rats by reducing oxidative stress and inflammation. Pediatr Res 2024; 96(7): 1681-92.
[http://dx.doi.org/10.1038/s41390-024-03246-9] [PMID: 38763946]
[17]
Peng P, Zou J, Zhong B, Zhang G, Zou X, Xie T. Protective effects and mechanisms of flavonoids in renal ischemia-reperfusion injury. Pharmacology 2023; 108(1): 27-36.
[http://dx.doi.org/10.1159/000527262]
[18]
Wang W, Tai S, Cheng X, et al. Protective role of exosomes in renal ischemia-reperfusion injury: A systematic review and meta-analysis. Front Pharmacol 2025; 16: 1653907.
[http://dx.doi.org/10.3389/fphar.2025.1653907]
[19]
Kompa AR, Khong FL, Zhang Y, et al. NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction. Life Sci 2022; 289: 120220.
[http://dx.doi.org/10.1016/j.lfs.2021.120220] [PMID: 34902438]
[20]
Aladag T, Acar G, Mogulkoc R, Baltaci AK. Improvement of neuronal and cognitive functions following treatment with 3′,4′ dihydroxyflavonol in experimental focal cerebral ischemia-reperfusion injury in rats. Eur J Pharmacol 2024; 976: 176670.
[http://dx.doi.org/10.1016/j.ejphar.2024.176670] [PMID: 38795755]
[21]
Zhao Q, Yan T, Chopp M, Venkat P, Chen J. Brain–kidney interaction: Renal dysfunction following ischemic stroke. J Cereb Blood Flow Metab 2020; 40(2): 246-62.
[http://dx.doi.org/10.1177/0271678X19890931] [PMID: 31766979]
[22]
Dulam V, Katta S, Nakka VP. Stroke and distal organ damage: Exploring brain-kidney crosstalk. Neurochem Res 2024; 49(7): 1617-27.
[http://dx.doi.org/10.1007/s11064-024-04126-8] [PMID: 38376748]
[23]
Wang IK, Liu CH, Yen TH, et al. Renal function is associated with 1-month and 1-year mortality in patients with ischemic stroke. Atherosclerosis 2018; 269: 288-93.
[http://dx.doi.org/10.1016/j.atherosclerosis.2017.11.029] [PMID: 29254692]
[24]
Chwojnicki K, Król E, Wierucki Ł, et al. Renal dysfunction in post-stroke patients. PLoS One 2016; 11(8): 0159775.
[http://dx.doi.org/10.1371/journal.pone.0159775] [PMID: 27575370]
[25]
Haselton JR, Vari RC. Neuronal cell bodies in paraventricular nucleus affect renal hemodynamics and excretion via the renal nerves. Am J Physiol 1998; 275(4): R1334-42.
[http://dx.doi.org/10.1152/ajpregu.1998.275.4.R1334] [PMID: 9756566]
[26]
Green HD, Hoff EC. Effects of faradic stimulation of the cerebral cortex on limb and renal volumes in the cat and monkey. Am J Physiol 1937; 118(4): 641-58.
[http://dx.doi.org/10.1152/ajplegacy.1937.118.4.641]
[27]
Butcher KS, Cechetto DF. Insular lesion evokes autonomic effects of stroke in normotensive and hypertensive rats. Stroke 1995; 26(3): 459-65.
[http://dx.doi.org/10.1161/01.STR.26.3.459] [PMID: 7886725]
[28]
Mracsko E, Liesz A, Karcher S, Zorn M, Bari F, Veltkamp R. Differential effects of sympathetic nervous system and hypothalamic–pituitary–adrenal axis on systemic immune cells after severe experimental stroke. Brain Behav Immun 2014; 41: 200-9.
[http://dx.doi.org/10.1016/j.bbi.2014.05.015] [PMID: 24886966]
[29]
Smets P, Meyer E, Maddens B, Daminet S. Cushing’s syndrome, glucocorticoids and the kidney. Gen Comp Endocrinol 2010; 169(1): 1-10.
[http://dx.doi.org/10.1016/j.ygcen.2010.07.004] [PMID: 20655918]
[30]
Fujii T, Kurata H, Takaoka M, et al. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur J Pharmacol 2003; 481(2-3): 241-8.
[http://dx.doi.org/10.1016/j.ejphar.2003.09.036] [PMID: 14642792]
[31]
Mogi M, Kawajiri M, Tsukuda K, Matsumoto S, Yamada T, Horiuchi M. Serum levels of renin-angiotensin system components in acute stroke patients. Geriatr Gerontol Int 2014; 14(4): 793-8.
[http://dx.doi.org/10.1111/ggi.12167] [PMID: 24279732]
[32]
Zhang W, Wang W, Yu H, et al. Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension 2012; 59(1): 136-44.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.173328] [PMID: 22068875]
[33]
Joynt RJ, Feibel JH, Sladek CM. Antidiuretic hormone levels in stroke patients. Ann Neurol 1981; 9(2): 182-4.
[http://dx.doi.org/10.1002/ana.410090212] [PMID: 7235633]
[34]
Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol 2013; 3(2): 957-76.
[http://dx.doi.org/10.1002/j.2040-4603.2013.tb00511.x] [PMID: 23720336]
[35]
Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol 2013; 9(8): 459-69.
[http://dx.doi.org/10.1038/nrneph.2013.110] [PMID: 23774812]
[36]
Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006; 37(8): 2018-23.
[http://dx.doi.org/10.1161/01.STR.0000231872.86071.68] [PMID: 16809555]
[37]
Stuveling EM, Hillege HL, Bakker SJL, Gans ROB, de Jong PE, de Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 2003; 63(2): 654-61.
[http://dx.doi.org/10.1046/j.1523-1755.2003.00762.x] [PMID: 12631131]
[38]
Wang W, Koka V, Lan H. Transforming growth factor‐β and Smad signalling in kidney diseases. Nephrology 2005; 10(1): 48-56.
[http://dx.doi.org/10.1111/j.1440-1797.2005.00334.x] [PMID: 15705182]
[39]
Wytrykowska A, Prosba-Mackiewicz M, Nyka WM. IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke. J Oral Sci 2016; 58(4): 509-13.
[http://dx.doi.org/10.2334/josnusd.16-0278] [PMID: 28025434]
[40]
Chodobski A, Zink BJ, Szmydynger-Chodobska J. Blood-brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res 2011; 2(4): 492-516.
[http://dx.doi.org/10.1007/s12975-011-0125-x] [PMID: 22299022]
[41]
Baud L, Ardaillou R. Reactive oxygen species: Production and role in the kidney. Am J Physiol 1986; 251(5 Pt 2): F765-76.
[http://dx.doi.org/10.1152/ajprenal.1986.251.5.F765] [PMID: 3022602]

Rights & Permissions Print Cite